Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on PolyNovo.
RELATED STOCKHEAD STORIES
Health & Biotech
Biocurious: From drug prices to efficiency drives, ASX biotechs await the ‘Trumpcare’ health fallout
Health & Biotech
Scott Power: S&P/ASX 200 Health Care Index falls but which stocks are up on positive news?
Health & Biotech
Scott Power: ACCC’s approval of Sigma, Chemist Warehouse union turned heads this week
Health & Biotech
Biocurious: With Singaporean approval ticked off, Orthocell eyes the crucial US nerve-repair market
Health & Biotech
Aussie made: ASX firms boosting local health & medical manufacturing
Health & Biotech
ScoPo’s Powerplays: ASX health stocks up in ‘fairly lacklustre week’
News
Closing Bell: Rotating to new highs, global markets are busy popping small caps back into their assets
News
Small Caps Lunch Wrap: Markets are down but who cares when these ASX penny stocks have gone quite mad
Health & Biotech
ScoPo’s Powerplays: ASX health stocks rise as Polynovo achieves record $10m revenue month
News
Closing Bell: Iceni Gold skyrockets 300pc on ‘spectacular discovery’; Perpetual to split up
News
Small Caps Lunch Wrap: ASX flatter than Tassie roadkill, but Pure Foods cap raise causes a stir on Apple Isle
Health & Biotech
ASX Health Stocks: Polynovo notches record month, Island Pharma gets much needed cash for Phase 2a trial
News
Market Highlights: ASX to open higher again, a warning from RBA, and 5 small caps to watch today
Health & Biotech
ScoPo’s Powerplays: ASX Health stocks rise in big week of quarterly reports
News
ASX Small Caps Lunch Wrap: Osteopore’s gone 1000% bananas, and here’s the rest of the news.
Health & Biotech
ImpediMed’s new leadership team looks to grow the company
Health & Biotech
